| Date | Time | Source | Headline | Symbol | Company |
| 07/18/2013 | 2:30PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 2:30PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 2:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 2:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 2:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 2:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 2:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 1:50PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 12:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/18/2013 | 10:39AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/16/2013 | 12:43PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/16/2013 | 11:00AM | PR Newswire (US) | Omthera Stockholders Approve Acquisition by AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/11/2013 | 8:13AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/10/2013 | 4:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/09/2013 | 8:59AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/09/2013 | 8:59AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 07/09/2013 | 5:00AM | PR Newswire (US) | Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 06/27/2013 | 10:54AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
